A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00401-019-02026-8
PubMed Identifier: 31131421
Publication URI: http://europepmc.org/abstract/MED/31131421
Type: Journal Article/Review
Volume: 138
Parent Publication: Acta neuropathologica
Issue: 2
ISSN: 0001-6322